In addition, studying the mechanisms of this disease in depth can help design drug treatments by enhancing the activity or stability of IRS1, which may help improve insulin sensitivity and provide new ideas for the treatment of T2DM, as well as a deeper understanding of the multiple roles of specific genes, such as IRS1, in physiology, pathology, and drug discovery. This evidence concerns the gene INS and type 2 diabetes mellitus.